Skip to main content
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1993 May;85(5):361–366.

Magnetic resonance imaging of the central nervous system in children with a new nonionic gadolinium contrast agent--gadoteridol injection (ProHance).

S E Byrd 1, C F Darling 1, M A Wilczynski 1
PMCID: PMC2571821  PMID: 8496990

Abstract

This article reports the results of clinical testing in pediatric patients of a new contrast agent, gadoteridol injection (ProHance), developed by Squibb Diagnostic as a nonionic gadolinium agent for use in magnetic resonance imaging (MRI). Thirteen children (four girls and nine boys) ranging in age from 10 to 18 years were enrolled in the study. The children had MR studies of the brain and/or spine with T1-weighted, T2-weighted, and postgadoteridol injection T1-weighted sequences. Five children had primary brain or spine neoplasms, three children had metastatic disease to the central nervous system, one child had a recurrent brain neoplasm and spinal canal metastasis, one child had an arteriovenous malformation, and two children were normal on the MRI studies. No minor or major reactions to gadoteridol injection developed in the 13 patients. Gadoteridol injection provided excellent delineation and enhancement of the arteriovenous malformation and all of the primary and secondary neoplasms of the central nervous system except for one case of a grade 1 glioma of the midbrain. Gadoteridol injection is a safe and excellent contrast agent for use in MRI.

Full text

PDF
361

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baierl P., Mühlsteffen A., Haustein J., Bauer W. M., Förster C., Fendel H., Niendorf H. P. Comparison of plain and Gd-DTPA-enhanced MR-imaging in children. Pediatr Radiol. 1990;20(7):515–519. doi: 10.1007/BF02011379. [DOI] [PubMed] [Google Scholar]
  2. Kirsch J. E. Basic principles of magnetic resonance contrast agents. Top Magn Reson Imaging. 1991 Mar;3(2):1–18. [PubMed] [Google Scholar]
  3. Lim V., Sobel D. F., Zyroff J. Spinal cord pial metastases: MR imaging with gadopentetate dimeglumine. AJNR Am J Neuroradiol. 1990 Sep-Oct;11(5):975–982. [PMC free article] [PubMed] [Google Scholar]
  4. McAlister W. H., McAlister V. I., Kissane J. M. The effect of Gd-dimeglumine on subcutaneous tissues: a study with rats. AJNR Am J Neuroradiol. 1990 Mar-Apr;11(2):325–327. [PMC free article] [PubMed] [Google Scholar]
  5. Runge V. M. Clinical applications of magnetic resonance contrast media in the head. Top Magn Reson Imaging. 1991 Mar;3(2):19–40. [PubMed] [Google Scholar]
  6. Yousem D. M., Patrone P. M., Grossman R. I. Leptomeningeal metastases: MR evaluation. J Comput Assist Tomogr. 1990 Mar-Apr;14(2):255–261. doi: 10.1097/00004728-199003000-00018. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES